300942 易瑞生物
按盤價 
7.900 -0.400 (-4.819%)
7.900 -0.400 (-4.819%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -1.141 | 1.550 | 1.993 | -20.388 | 8.689 |
| 總資產報酬率 ROA (%) | -0.681 | 0.922 | 1.217 | -14.015 | 6.814 |
| 投入資產回報率 ROIC (%) | -0.748 | 1.005 | 1.316 | -15.477 | 7.659 | 邊際利潤分析 |
| 銷售毛利率 (%) | 55.798 | 63.983 | 70.628 | 49.929 | 56.506 |
| 營業利潤率 (%) | -22.804 | 2.119 | 9.349 | -68.987 | 14.283 |
| 息稅前利潤/營業總收入 (%) | -2.804 | 11.710 | 12.285 | -71.069 | 12.577 |
| 淨利潤/營業總收入 (%) | -18.190 | 5.876 | 7.411 | -72.798 | 12.034 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 121.244 | 21.194 | 70.945 | 44.059 | 138.511 |
| 價值變動淨收益/利潤總額(%) | -10.140 | -39.103 | -20.205 | 30.419 | 2.820 |
| 營業外收支淨額/利潤總額(%) | -0.415 | 58.026 | -6.480 | 1.404 | -3.395 | 償債能力分析 |
| 流動比率 (X) | 7.293 | 5.089 | 4.946 | 5.387 | 3.376 |
| 速動比率 (X) | 6.724 | 4.748 | 4.680 | 5.158 | 2.872 |
| 資產負債率 (%) | 39.553 | 40.462 | 40.278 | 37.425 | 24.777 |
| 帶息債務/全部投入資本 (%) | 31.733 | 30.903 | 35.666 | 29.327 | 10.962 |
| 股東權益/帶息債務 (%) | 205.350 | 213.406 | 178.619 | 234.117 | 763.464 |
| 股東權益/負債合計 (%) | 151.837 | 146.560 | 148.061 | 167.253 | 303.659 |
| 利息保障倍數 (X) | -0.141 | 1.758 | 3.505 | 64.635 | -10.167 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 165.505 | 139.682 | 136.622 | 113.357 | 47.412 |
| 存貨周轉天數 (天) | 206.721 | 180.751 | 196.462 | 186.842 | 117.164 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 27/04/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
